Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001445849 | SCV001648888 | likely benign | Neurofibromatosis, type 1 | 2024-11-06 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV001820139 | SCV002068775 | likely benign | not specified | 2017-08-14 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001445849 | SCV002561112 | likely benign | Neurofibromatosis, type 1 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004557656 | SCV005047393 | likely benign | Hereditary cancer-predisposing syndrome; Cardiovascular phenotype | 2023-09-28 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |